Molina Healthcare stock falls 1.49 percent as coverage shifts

Molina Healthcare stock (ISIN US60855R1005) closed at USD 197.80 on the NYSE on September 21, 2026, down 1.49 percent from the prior close. The company enters the next reporting cycle with second-quarter earnings above consensus, while a Medicare Advantage product exit remains a concrete operating issue.

EPS beats consensus by USD 0.12

Molina Healthcare reported Q2 FY26 revenue of USD 10.87 billion and earnings of USD 60 million, according to Yahoo Finance. The same reporting snapshot lists diluted EPS of USD 1.51, compared with a consensus estimate of USD 1.39, a beat of USD 0.12 for Q2 FY26.

The comparison is more nuanced than the earnings beat alone. MarketBeat reported on September 21, 2026, that quarterly revenue was down 4.8 percent from the same quarter a year earlier, even though EPS exceeded consensus by USD 0.12.

Medicare Advantage exit changes mix

On September 22, 2026, 247 Wall St reported that Molina plans to end its traditional Medicare Advantage drug plans on December 31, 2026. The product was expected to generate approximately USD 1 billion in 2026 premium revenue, making the decision material for the near-term revenue mix.

The timing also creates a member-transition checkpoint. The report states that affected members will receive letters in October 2026, while the annual enrollment period runs from October 15 through December 7, 2026. For investors, the key comparison is between the USD 1 billion premium stream being exited and the company's ability to replace that volume without weakening margins.

Stock remains below analyst average target

Yahoo Finance lists an average analyst price target of USD 209.12, with a low of USD 147.00 and a high of USD 266.00, against the USD 197.80 NYSE close on September 21, 2026. The same page records a target revision from USD 235 to USD 220, giving the coverage picture a more cautious tone than the Q2 EPS beat.

Molina Healthcare's market capitalization was USD 10.325 billion on the September 22, 2026 quote snapshot, while the next earnings date shown by Yahoo Finance is October 21, 2026. That date is the next checkpoint for whether the Q2 revenue decline remains a one-quarter comparison issue or develops into a broader membership and margin trend.

NYSE close holds the reference

The reference price was USD 197.80 on the NYSE at 4:00 p.m. Eastern Time on September 21, 2026, with a daily change of negative 1.49 percent. The earnings beat of USD 0.12 over consensus and the planned USD 1 billion product exit frame the two competing forces in the stock's current setup.

More news and analyses on Molina Healthcare stock